In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than dapagliflozin at 40 wk.
Medicine
Abstract
CLINICAL IMPACT RATINGS GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].